Chemo timing before vs after colon cancer surgery
Part of Cancer, Digestive system clinical trials.
This Phase 3 study compares two schedules of a colon cancer chemo combination: starting before surgery or starting after surgery. It aims to see which timing helps people live longer and lowers cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have locally advanced colon cancer and can undergo surgery or a procedure soon
- You can do usual daily activities at a limited or near-normal level (ECOG 0–2)
- Recent blood tests (done within 7 days) are strong enough: white cells, platelets, and hemoglobin are above set minimums
- Your liver and kidney blood tests are within allowed ranges
- You have not had chemotherapy for colon cancer before, and you are not taking other chemo at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy (CapeOX), a targeted drug (bevacizumab), and an immunotherapy (anti-PD1) given before surgery for colorectal cancer that has come back locally (in the same area). The goal is to shrink the tumor and improve surgical outcomes.
This Phase 2 trial studies giving chemotherapy plus immune therapy before surgery for certain colon cancers that do not have mismatch repair defects (MSS/pMMR). The goal is to shrink and control the tumor and improve outcomes compared with standard approaches.
This trial tests a combination of chemo, a medicine that blocks blood vessel growth, and an immune checkpoint drug given before rectal cancer surgery. It’s for people with locally advanced rectal cancer without distant spread, to try to shrink the tumor and improve surgical results.
This trial tests whether giving chemotherapy followed by an immunotherapy drug (a checkpoint inhibitor) before surgery helps shrink locally advanced colon cancer. It is for people with a specific tumor type (MSS and RAS mutation) who have not had prior treatment.
This trial studies whether adding CAPEOX chemotherapy after surgery can help people with colon cancer who have a “positive MRD” blood test result (meaning tiny amounts of cancer may still be present). It compares chemo versus active observation to see if chemo improves outcomes while keeping safety in mind.
This trial tests whether giving chemotherapy before surgery can improve outcomes for people with colon cancer that has grown into nearby tissue or lymph nodes but hasn't spread to other organs. It is for patients whose tumors are mismatch repair proficient (pMMR) or microsatellite stable (MSS).
Hear when a new Locally Advanced Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.